Updated recommendations are presented for the use of medications among patients with rheumatic disease undergoing elective total hip arthroplasty (THA) and total knee arthroplasty (TKA).
The American Heart Association addresses concerns on the use of intramuscular benzathine penicillin G injections in patients with rheumatic heart disease.
Thrombocytopenia at hospital admission may be an independent predictor for in-hospital mortality in patients with rheumatic heart disease undergoing valve replacement surgery.
